You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Karyopharm

Showing 26 - 50 of 74
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma, Relapsed and/or Refractory Multiple Myeloma Trial in United States (Selinexor, Ixazomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • Relapsed and/or Refractory Multiple Myeloma
  • Basking Ridge, New Jersey
  • +6 more
Nov 23, 2020

Myelofibrosis, Moderate Thrombocytopenia Trial (Selinexor)

Not yet recruiting
  • Myelofibrosis
  • Moderate Thrombocytopenia
  • (no location specified)
Jul 31, 2023

Relapsed Refractory Multiple Myeloma Trial in United States (Abemaciclib, dexamethasone, ixazomib, pomalidomide, Enasidenib,

Recruiting
  • Relapsed Refractory Multiple Myeloma
  • Abemaciclib, dexamethasone, ixazomib, pomalidomide
  • +7 more
  • Phoenix, Arizona
  • +16 more
Sep 9, 2021

Leukemia, Acute Myeloid Leukemia Trial in Houston (Selinexor, Sorafenib)

Completed
Has Results
  • Leukemia
  • Acute Myeloid Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 18, 2020

Multiple Myeloma Trial in West Hollywood, Cary (Selinexor, Placebo (for selinexor), carfilzomib)

Withdrawn
  • Multiple Myeloma
  • West Hollywood, California
  • +1 more
Jan 24, 2023

Endometrial Cancer Trial in Israel, United States (Selinexor, Matching Placebo for selinexor)

Recruiting
  • Endometrial Cancer
  • Miami Beach, Florida
  • +6 more
Jan 31, 2023

Solid Tumors, NHL Trial in Canada, United States (KPT-9274, Niacin ER, Nivolumab)

Terminated
  • Solid Tumors
  • NHL
  • Los Angeles, California
  • +7 more
Jan 18, 2023

Acute Myeloid Leukemia Trial in Saint Louis (Selinexor, Cladribine, G-CSF)

Completed
Has Results
  • Acute Myeloid Leukemia
  • Saint Louis, Missouri
    Washington University School of Medicine
Mar 6, 2020

Myelofibrosis Trial in United States (Selinexor, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • Duarte, California
  • +4 more
Jan 30, 2023

Locally Advanced Unresectable or Metastatic Melanoma Trial in United States (Selinexor, Pembrolizumab)

Recruiting
  • Locally Advanced Unresectable or Metastatic Melanoma
  • Los Angeles, California
  • +12 more
Jun 30, 2022

Myelofibrosis Trial in Worldwide (Selinexor, Physician's Choice Treatment)

Recruiting
  • Myelofibrosis
  • Los Angeles, California
  • +41 more
Jan 30, 2023

Coronavirus Infection Trial (Selinexor)

Withdrawn
  • Coronavirus Infection
  • (no location specified)
Jan 19, 2023

Multiple Myeloma Trial in Worldwide (Selinexor, Elotuzumab, Pomalidomide)

Recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +67 more
Jul 26, 2022

Metastatic Colorectal Cancer Trial in Los Angeles, Newark, Plantation (Selinexor, Pembrolizumab, Trifluridine)

Terminated
  • Metastatic Colorectal Cancer
  • Los Angeles, California
  • +2 more
Jan 24, 2023

Acute Myeloid Leukemia (AML) Trial in United States (Selinexor, Fludarabine, Cytarabine)

Terminated
Has Results
  • Acute Myeloid Leukemia (AML)
  • Phoenix, Arizona
  • +6 more
May 20, 2020

Carcinoma, Neuroendocrine Trial in Canton (Selinexor)

Completed
  • Carcinoma, Neuroendocrine
  • Canton, Ohio
    Gabrail Cancer Center Research
Sep 13, 2019

Multiple Myeloma, Refractory Trial in Greece, Israel (Selinexor, Dexamethasone, Bortezomib)

Recruiting
  • Multiple Myeloma, Refractory
  • Patra, Achaia, Greece
  • +15 more
Apr 4, 2022

Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndrome (MDS) Trial in United States

Completed
  • Acute Myeloid Leukemia (AML)
  • +3 more
  • Phoenix, Arizona
  • +5 more
Mar 25, 2020

Non-Small Cell Lung Carcinoma (NSCLC), Colorectal Cancer (CRC), Other Solid Tumors Trial in Israel (Selinexor 100 mg, Docetaxel,

Recruiting
  • Non-Small Cell Lung Carcinoma (NSCLC)
  • +2 more
  • Selinexor 100 mg
  • +6 more
  • Ashdod, Israel
  • +10 more
Jan 30, 2023

Relapsed or Refractory DLBCL Trial in United States (Selinexor, Rituximab, Bendamustine)

Suspended
  • Relapsed or Refractory Diffuse Large B-Cell Lymphoma
  • Tucson, Arizona
  • +17 more
Jan 24, 2023

Endometrial Cancer Trial in Worldwide (Selinexor, Matching for selinexor)

Active, not recruiting
  • Endometrial Cancer
  • Tucson, Arizona
  • +104 more
Aug 11, 2022

Relapsed/Refractory Diffuse Large B-cell Lymphoma Trial in Worldwide (Selinexor (combination therapy), Placebo matching for

Recruiting
  • Relapsed/Refractory Diffuse Large B-cell Lymphoma
  • Selinexor (combination therapy)
  • +7 more
  • Chandler, Arizona
  • +51 more
May 6, 2022

Glioblastoma, Glioma Trial in Denmark, Netherlands, United States (Selinexor)

Terminated
Has Results
  • Glioblastoma
  • Glioma
  • Boston, Massachusetts
  • +5 more
Jan 24, 2023

Glioblastoma Multiforme Trial in Canada, United States (drug, radiation, device)

Recruiting
  • Glioblastoma Multiforme
  • Birmingham, Alabama
  • +17 more
Apr 1, 2022

Multiple Myeloma Trial in Worldwide (Selinexor, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Birmingham, Alabama
  • +60 more
Jan 24, 2023